Evidence map›Paper›PMID 23761301›Full record

ReviewMolecular pharmacology2013

Oral benzo[a]pyrene: understanding pharmacokinetics, detoxication, and consequences--Cyp1 knockout mouse lines as a paradigm.

Daniel W Nebert, Zhanquan Shi, Marina Gálvez-Peralta, Shigeyuki Uno, Nadine Dragin

Open access · bronzeAbstract readReview
In one paragraph

Review in Molecular pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 127 citations in OpenAlex.

  1. Review
  2. The Aryl Hydrocarbon Receptor (AHR): Peacekeeper of the Skin.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Benzo[International journal of molecular sciences · 2022
    Review
  8. Effect of polycyclic aromatic hydrocarbons on immunity.Journal of translational autoimmunity · 2022
    Article
  9. Review
  10. Article
  11. Benzo[International journal of molecular sciences · 2021
    Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Human Health and Ocean Pollution.Annals of global health · 2020
    Review
  19. Interaction ofMarine drugs · 2020
    Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Daniel W NebertDepartment of Environmental Health, and the Center for Environmental Genetics, University of Cincinnati Medical Center, P.O. Box 670056, Cincinnati, OH 45267-0056, USA. dan.nebert@uc.edu
Zhanquan Shi
Marina Gálvez-Peralta
Shigeyuki Uno
Nadine Dragin
University of Cincinnati · USUniversity of Cincinnati Medical Center · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
CYPIAI GENE AND ENVIRONMENTAL ToxicityR01ES008147 · NIEHS · UNIVERSITY OF CINCINNATI · PI NEBERT, DANIEL W. · 1996 to 2005
$2.5M
Gene-Environment Interactinos Training ProgramT32ES016646 · NIEHS · UNIVERSITY OF CINCINNATI · PI PUGA, ALVARO · 2008 to 2014
$2.1M
PAHs: Balance of Detoxication vs Metabolic ActivationR01ES014403 · NIEHS · UNIVERSITY OF CINCINNATI · PI NEBERT, DANIEL W. · 2006 to 2009
$1.4M
NIEHS NIH HHS P30 ES006096NIEHS NIH HHS R01 ES008147NIEHS NIH HHS R01 ES014403NIEHS NIH HHS T32 ES016646
6 · The paper itself

Abstract

Benzo[a]pyrene (BaP) is a prototypical polycyclic aromatic hydrocarbon (PAH); this ubiquitous environmental carcinogenic agent is found in tobacco smoke, charcoal-grilled foods, and PAH-contaminated surfaces of roofs, playgrounds, and highways. Cytochrome P450 1 wild-type, Cyp1a2(-/-), Cyp1b1(-/-), or Cyp1a2/1b1(-/-) knockouts, and mice with Cyp1a1 expression deleted in hepatocytes can ingest large oral BaP doses (125 mg/kg/d) without apparent toxicity. Cyp1a1(-/-) and Cyp1a1/1a2(-/-) knockouts and mice with Cyp1a1 expression deleted in gastrointestinal (GI) tract epithelial cells develop immunotoxicity and die within 32 days, indicating that GI tract inducible CYP1A1 is absolutely required for detoxication of oral BaP. Cyp1a1/1b1(-/-) and Cyp1a1/1a2/1b1(-/-) mice are rescued from immunosuppression and early death due to absent metabolic activation of BaP by CYP1B1 in immune cells. Ten-fold lower oral BaP doses result in adenocarcinoma of the proximal small intestine (PSI) in Cyp1a1(-/-) mice; Cyp1a1/1b1(-/-) double-knockout mice show no PSI cancer but develop squamous cell carcinoma of the preputial gland duct (PGD). BaP-metabolizing CYP1B1 in the PSI and CYP3A59 in the PGD are the most likely candidates to participate in tumor initiation in the epithelial cells of these two tissues; oncogenes and tumor-suppressor genes upregulated and downregulated during tumorigenesis are completely different between these tissues. This "oral BaP Cyp1" mouse paradigm represents a powerful teaching tool, showing that gene-environment interactions depend on route-of-administration: the same oral, but not intraperitoneal, BaP exposure leads to dramatic differences in target-organ toxicity and tumor type as a function of dose and Cyp1 genotype.

Indexed as

Administration, OralAnimalsAryl Hydrocarbon HydroxylasesBenzo(a)pyreneCarcinogens, EnvironmentalCytochrome P-450 CYP1A1Cytochrome P-450 CYP1A2Cytochrome P-450 CYP1B1Dose-Response Relationship, DrugGene-Environment InteractionIntestinal NeoplasmsMetabolic Detoxication, Phase IIMiceMice, KnockoutNeoplasms, ExperimentalOrgan SpecificityAryl Hydrocarbon HydroxylasesBenzo(a)pyreneCarcinogens, EnvironmentalCyp1b1 protein, mouseCytochrome P-450 CYP1A1Cytochrome P-450 CYP1A2Cytochrome P-450 CYP1B1

Identifiers

PMID23761301
PMCPMC3876811
OpenAlexW2115987919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.